Industry › BioTech
Press Releases
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
HighTide Therapeutics Inc.
Jun 05, 2024 09:00 HKT/SGT
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果，进一步展现熊去氧胆小檗碱（HTD1801）的疗效与安全性
HighTide Therapeutics Inc.
Jun 05, 2024 09:00 HKT/SGT
BIO24에서 발표된 새로운 연구에서 내부 규제 사항을 갖춘 CRO는 생명공학 기업에게 30%의 절감을 제공하고, 시간을 절반으로 줄이며, 위험을 줄입니다
Avance Clinical
Jun 04, 2024 22:56 HKT/SGT
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs
Avance Clinical
Jun 04, 2024 22:00 HKT/SGT
Avance Clinical通过与Julius Clinical合作，在欧洲扩展专门的中枢神经系统、心血管代谢和罕见疾病的CRO服务
Avance Clinical
Jun 01, 2024 06:00 HKT/SGT
Avance Clinical透過與Julius Clinical合作，在歐洲擴展專門的中樞神經系統、心血管代謝和罕見疾病的CRO服務
Avance Clinical
Jun 01, 2024 06:00 HKT/SGT
Avance Clinical, Julius Clinical과 함께 유럽에서 중추신경계(CNS), 심장대사 및 희귀 질환 전문 CRO 서비스를 확장하다
Avance Clinical
Jun 01, 2024 06:00 HKT/SGT
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical
May 31, 2024 16:00 HKT/SGT
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
BioMed X Institute
May 28, 2024 18:00 HKT/SGT
LEQEMBI (lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea
Eisai
May 28, 2024 14:19 HKT/SGT
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
BioMed X Institute
May 16, 2024 22:00 HKT/SGT